Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cara-Lin Lonetree

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Stem Cells (Dayton, Ohio)|April 23, 2013
A new immuno-, dystrophin-deficient model, the NSG-mdx(4Cv) mouse, provides evidence for functional improvement following allogeneic satellite cell transplantationRobert W Arpke, Radbod Darabi, Tara L Mader, et al.
Stem Cells and Development|August 20, 2016
CRISPR/Cas9 Targeted Gene Editing and Cellular Engineering in Fanconi AnemiaMark Osborn, Cara-Lin Lonetree, Beau R Webber, et al.
International Journal of Molecular Sciences|September 9, 2022
A Pan-RNase Inhibitor Enabling CRISPR-mRNA Platforms for Engineering of Primary Human MonocytesKanut Laoharawee, Matthew J Johnson, Walker S Lahr, et al.
NPJ Regenerative Medicine|March 3, 2017
CRISPR/Cas9-based genetic correction for recessive dystrophic epidermolysis bullosaBeau R Webber, Mark J Osborn, Amber N McElroy, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|November 10, 2019
A Genetically Engineered Primary Human Natural Killer Cell Platform for Cancer ImmunotherapyEmily J Pomeroy, John T Hunzeker, Mitchell G Kluesner, et al.
Nature Communications|December 8, 2019
Author Correction: Highly efficient multiplex human T cell engineering without double-strand breaks using Cas9 base editorsBeau R Webber, Cara-Lin Lonetree, Mitchell G Kluesner, et al.
Nature Communications|November 21, 2019
Highly efficient multiplex human T cell engineering without double-strand breaks using Cas9 base editorsBeau R Webber, Cara-Lin Lonetree, Mitchell G Kluesner, et al.
Nature Communications|April 24, 2021
CRISPR-Cas9 cytidine and adenosine base editing of splice-sites mediates highly-efficient disruption of proteins in primary and immortalized cellsMitchell G Kluesner, Walker S Lahr, Cara-Lin Lonetree, et al.
Biorxiv : the Preprint Server for Biology|August 12, 2025
A Singular Base Editing Platform for Polyfunctional Multiplex Engineering of Immune CellsJoseph G Skeate, Nicholas J Slipek, Walker S Lahr, et al.
Cancer Immunology Research|March 12, 2025
IL-15 Complex Enhances Agonistic Anti-CD40 + Anti-PDL1 by Correcting the T-bet to Tox Ratio in CD8+ T cells Infiltrating Pancreatic Ductal AdenocarcinomaZoe C Schmiechen, Hezkiel A Nanda, Adam L Burrack, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Stem Cells (Dayton, Ohio)|April 23, 2013
A new immuno-, dystrophin-deficient model, the NSG-mdx(4Cv) mouse, provides evidence for functional improvement following allogeneic satellite cell transplantationRobert W Arpke, Radbod Darabi, Tara L Mader, et al.
Stem Cells and Development|August 20, 2016
CRISPR/Cas9 Targeted Gene Editing and Cellular Engineering in Fanconi AnemiaMark Osborn, Cara-Lin Lonetree, Beau R Webber, et al.
International Journal of Molecular Sciences|September 9, 2022
A Pan-RNase Inhibitor Enabling CRISPR-mRNA Platforms for Engineering of Primary Human MonocytesKanut Laoharawee, Matthew J Johnson, Walker S Lahr, et al.
NPJ Regenerative Medicine|March 3, 2017
CRISPR/Cas9-based genetic correction for recessive dystrophic epidermolysis bullosaBeau R Webber, Mark J Osborn, Amber N McElroy, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|November 10, 2019
A Genetically Engineered Primary Human Natural Killer Cell Platform for Cancer ImmunotherapyEmily J Pomeroy, John T Hunzeker, Mitchell G Kluesner, et al.
Nature Communications|December 8, 2019
Author Correction: Highly efficient multiplex human T cell engineering without double-strand breaks using Cas9 base editorsBeau R Webber, Cara-Lin Lonetree, Mitchell G Kluesner, et al.
Nature Communications|November 21, 2019
Highly efficient multiplex human T cell engineering without double-strand breaks using Cas9 base editorsBeau R Webber, Cara-Lin Lonetree, Mitchell G Kluesner, et al.
Nature Communications|April 24, 2021
CRISPR-Cas9 cytidine and adenosine base editing of splice-sites mediates highly-efficient disruption of proteins in primary and immortalized cellsMitchell G Kluesner, Walker S Lahr, Cara-Lin Lonetree, et al.
Biorxiv : the Preprint Server for Biology|August 12, 2025
A Singular Base Editing Platform for Polyfunctional Multiplex Engineering of Immune CellsJoseph G Skeate, Nicholas J Slipek, Walker S Lahr, et al.
Cancer Immunology Research|March 12, 2025
IL-15 Complex Enhances Agonistic Anti-CD40 + Anti-PDL1 by Correcting the T-bet to Tox Ratio in CD8+ T cells Infiltrating Pancreatic Ductal AdenocarcinomaZoe C Schmiechen, Hezkiel A Nanda, Adam L Burrack, et al.
Pageof 2